NCT06907303Enrolling by invitation
RNA Assays for Endometriosis Detection and Diagnosis
Development and Evaluation of RNA-based Markers for Detecting and Diagnosing Endometriosis
Source: ClinicalTrials.gov · Last updated 2 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Endometriosis is a common disease that affects up to 10% of women of reproductive age. Diagnosis, however, is typically delayed (up to 12 years) and is usually made after surgery. A key unmet need therefore is an accurate biomarker that can be used to detect the disease early. This study is a prospective trial to identify candidate mRNA-markers which can be used to aid in the diagnosis of this disease. It is a discovery/validation study that will identify and confirm a gene expression panel that is specific for endometriosis and provides a non-invasive tool for future use.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 25 Mar 2025
- Start date
- 1 Jan 2024
- Primary completion date
- 31 Aug 2025
- Lead sponsor
- Wren Laboratories LLC
- Diseases
- Endometriosis
- NCT number
- NCT06907303
What you commit to
- Study type: Observational
- Planned participants: 400
- From 1 Jan 2024 to the primary completion date, 31 Aug 2025
- 2 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- polycystic ovary syndrome, hyperprolactinemia
- severe cardiovascular system, liver, kidney, and hematopoietic system disease
- autoimmune disease
- uterine fibroids, endometritis, non-vegetative ovarian cysts, ovarian malignancies, and internal genital tuberculosis
Other
- For the endometriosis cohort
- \-
Who the study is looking for
- For the endometriosis cohort
- a history of infertility more than 1 year
- age 20-35 years
- normal liver and kidney function, without gynaecological and other systemic disease
- \-
Age in the registry: 20 years to 35 years · Sex: Female
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Wren Laboratories Coordinator of this site? Confirm its status | Branford | United States | Unknown status |
| University of Cape Town Coordinator of this site? Confirm its status | Cape Town | South Africa | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.